About Concord Biotech Ltd 
Concord Biotech Ltd
Small Cap
Pharmaceuticals & Biotechnology
Concord Biotech Limited was originally incorporated as `Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to `Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC.
Company Coordinates 
No Company Details Available
Capital Structure 
Present Equity Capital
INR 10.46 Cr
Number of Shares
10.46 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Jul-2022
10.46
10.46
9510564
1
Bonus Issue
08-Jul-2022
9.51
9.51
85595076
1
Stock Split
05-Jul-2016
95.11
9.51
305372
10
Preferential Allotment
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 24 Schemes (4.53%)
FIIs
Held by 102 FIIs (8.03%)
Promoter with highest holding
Sudhir Kumar Vaid (28.84%)
Highest Public shareholder
Aryavir Jhunjhunwala Discretionary Trust (8.03%)
Individual Investors Holdings
7.77%
Management
Designation
Remuneration
SUDHIR JAIRAM VAID
Chairman & Managing Director
5.02 cr
ANKUR VAID
Joint Managing Director & CEO
2.89 cr
Ravi Kapoor
Non Executive Director
2.2 lacs
Rajiv Agarwal
Nominee
2.2 lacs
Utpal Sheth
Nominee
70.0 k
Amit Varma
Nominee
0
BHARTI KHANNA
Independent Director
1.7 lacs
ANIL KATYAL
Independent Director
2.2 lacs
Amitabh Thakore
Independent Director
2.2 lacs
Arvind Agarwal
Independent Director
2.0 lacs
Jayaram Easwaran
Independent Director
2.0 lacs
Mandayam Chakravarthy Sriraman
Independent Director
1.5 lacs
S Prakash
Vice President & CS
37.8 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material Consumed
264.3126
0%
Raw Material Consumed
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Revenue and Profits:
Net Sales:
247 Cr
(Quarterly Results - Sep 2025)
Net Profit:
64 Cr
Pharmaceuticals & Biotechnology
INR 14,832 Cr (Small Cap)
45.00
34
0.76%
-0.18
17.73%
8.01






